Literature DB >> 23001294

Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.

Yoshinobu Hoshii1, Hidemi Nanbara, Dan Cui, Mutsuo Takahashi, Eiji Ikeda.   

Abstract

For the purpose of investigating the carboxy terminus distribution of immunoglobulin κ light chain in Aκ amyloid deposits in tissue sections, we examined the immunostaining pattern of Aκ amyloidosis with conventional rabbit clonal antibody against peptide derived from the C-terminal sequence of human κ light chain. This antihuman kappa light chain clone II (clone H16-E) reacted with the adjacent region of the C terminus of the κ light chain constant region in SPOT analysis. Immunohistochemically, this antibody reacted with amyloid deposits in all 18 cases of Aκ amyloidosis. In 15 cases, this antibody reacted with amyloid deposits almost uniformly. In this study, we demonstrated for the fi rst time that the peptides adjacent to the carboxy terminus of immunoglobulin κ light chain or full-length κ light chain were constituents of Aκ amyloidosis, and these molecules were distributed uniformly in almost all cases of Aκ amyloidosis in tissue sections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001294     DOI: 10.1007/s00795-011-0548-1

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  16 in total

1.  Plasmacytoma of the tonsil with AL amyloidosis: evidence of post-fibrillogenic proteolysis of the fibril protein.

Authors:  C Röcken; V Hegenbarth; M Schmitz; B Stix; G Schade; A Mohnert; A Roessner
Journal:  Virchows Arch       Date:  2000-04       Impact factor: 4.064

2.  Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis.

Authors:  Y Hoshii; M Setoguchi; T Iwata; J Ueda; D Cui; H Kawano; T Gondo; M Takahashi; T Ishihara
Journal:  Pathol Int       Date:  2001-04       Impact factor: 2.534

Review 3.  Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.

Authors:  J Buxbaum
Journal:  Hematol Oncol Clin North Am       Date:  1992-04       Impact factor: 3.722

4.  Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.

Authors:  J P Engvig; K E Olsen; R E Gislefoss; K Sletten; O Wahlström; P Westermark
Journal:  Scand J Immunol       Date:  1998-07       Impact factor: 3.487

5.  Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins.

Authors:  K E Olsen; K Sletten; P Westermark
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

6.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

7.  Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain.

Authors:  J Wally; G Kica; Y Zhang; T Ericsson; L H Connors; M D Benson; J J Liepnieks; J Murray; M Skinner; R L Comenzo
Journal:  Biochim Biophys Acta       Date:  1999-05-31

8.  Fibril protein fragmentation pattern in systemic AL-amyloidosis.

Authors:  Stina Enqvist; Knut Sletten; Per Westermark
Journal:  J Pathol       Date:  2009-12       Impact factor: 7.996

9.  Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations.

Authors:  A Gustavsson; U Engström; P Westermark
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  Light chain-associated amyloid deposits comprised of a novel kappa constant domain.

Authors:  A Solomon; D T Weiss; C L Murphy; R Hrncic; J S Wall; M Schell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more
  2 in total

Review 1.  Pathophysiology and treatment of cardiac amyloidosis.

Authors:  Morie A Gertz; Angela Dispenzieri; Taimur Sher
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

2.  Mass spectrometry-based absolute quantification of amyloid proteins in pathology tissue specimens: Merits and limitations.

Authors:  Makiko Ogawa; Yukako Shintani-Domoto; Yoshiki Nagashima; Koji L Ode; Aya Sato; Yoshihiro Shimizu; Kenichi Ohashi; Michael H A Roehrl; Tetsuo Ushiku; Hiroki R Ueda; Masashi Fukayama
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.